Magic truffle

Last updated
A Dutch Smart Shop with magic mushrooms and magic truffles on display in 2007 Paddo products Warmoesstraat Amsterdam april 2007.JPG
A Dutch Smart Shop with magic mushrooms and magic truffles on display in 2007

Magic truffles are the sclerotia of psilocybin mushrooms that are not technically the same as "mushrooms". They are masses of mycelium that contain the fruiting body which contains the hallucinogenic chemicals psilocybin and psilocin.

Contents

In October 2007, the prohibition of hallucinogenic or "magic mushrooms" was announced by the Dutch authorities. [1] [2] The ban on mushrooms did not outlaw the hallucinogenic species in sclerotium form, due to authorities believing it to be weaker than the mushrooms. Psilocybin truffles which once made little sales became the only legal option to produce. [3] Today, smart shops in the Netherlands offer magic truffles as a legal alternative to the outlawed mushrooms.

Addiction and Tolerance

Physical addiction to magic truffles has never been documented. As the psychoactive constituent of magic truffles is psilocybin, the prodrug to psilocin, addiction is not possible by conventional definitions. [4] Additionally, there is strong evidence to suggest there is little to no potential for psychological dependence on psilocybin. [5]

Tolerance to magic truffles specifically is not well researched. However, tolerance to psilocybin is a well understood concept, with repeatedly higher doses being needed in order to achieve the same effect, due to the down regulation of 5HT2A receptors. [6] There is also documented cross-tolerance between psilocybin and LSD, meaning that a higher dose of these substances is needed to get the same effect when a person consumes them with high frequency. Through temporary abstinence the tolerance returns to baseline. [7]

Species

There are five different types of truffles: Psilocybe mexicana (Jalisco/Mexicana A), Psilocybe tampanensis , Psilocybe galindoi , Psilocybe atlantis and Psilocybe pajaritos

See also

Related Research Articles

<span class="mw-page-title-main">Psilocybin</span> Chemical compound found in some species of mushrooms

Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of fungi. The most potent are members of genus Psilocybe, such as P. azurescens, P. semilanceata, and P. cyanescens, but psilocybin has also been isolated from about a dozen other genera. Psilocybin is itself biologically inactive but is quickly converted by the body to psilocin, which has mind-altering effects similar, in some aspects, to those of lysergic acid diethylamide (LSD), mescaline, and dimethyltryptamine (DMT). In general, the effects include euphoria, visual and mental hallucinations, changes in perception, distorted sense of time, and perceived spiritual experiences. It can also cause adverse reactions such as nausea and panic attacks.

<span class="mw-page-title-main">Psychedelic drug</span> Hallucinogenic class of psychoactive drug

Psychedelics are a subclass of hallucinogenic drugs whose primary effect is to trigger non-ordinary mental states and an apparent expansion of consciousness. Also referred to as classic hallucinogens or serotonergic hallucinogens, the term psychedelic is sometimes used more broadly to include various types of hallucinogens, such as those which are atypical or adjacent to psychedelia like salvia and MDMA, respectively. This article makes use of the narrower classical definition of psychedelics. Classic psychedelics generally cause specific psychological, visual, and auditory changes, and oftentimes a substantially altered state of consciousness. They have had the largest influence on science and culture, and include mescaline, LSD, psilocybin, and DMT.

<i>Psilocybe cubensis</i> Species of fungus

Psilocybe cubensis, commonly known as the magic mushroom, shroom, golden halo, cube, or gold cap, is a species of psilocybin mushroom of moderate potency whose principal active compounds are psilocybin and psilocin. It belongs to the fungus family Hymenogastraceae and was previously known as Stropharia cubensis. It is the best-known psilocybin mushroom due to its wide distribution and ease of cultivation. This mushroom being optimal for home cultivation specifically, as was suggested in the 1970s, is primarily what led to P. cubensis being the psilocybin mushroom species most common on the black market as a street drug.

<span class="mw-page-title-main">Psilocybin mushroom</span> Mushrooms containing psychoactive indole alkaloids

Psilocybin mushrooms, commonly known as magic mushrooms or shrooms, are a polyphyletic informal group of fungi that contain psilocybin, which turns into psilocin upon ingestion. Biological genera containing psilocybin mushrooms include Psilocybe, Panaeolus, Inocybe, Pluteus, Gymnopilus, and Pholiotina.

<i>Psilocybe</i> Genus of fungi

Psilocybe is a genus of gilled mushrooms, growing worldwide, in the family Hymenogastraceae. Most or nearly all species contain the psychedelic compounds psilocybin and psilocin.

<i>Psilocybe semilanceata</i> Species of fungus in the family Hymenogastraceae, native to Europe

Psilocybe semilanceata, commonly known as the liberty cap, is a species of fungus which produces the psychoactive compounds psilocybin, psilocin and baeocystin. It is both one of the most widely distributed psilocybin mushrooms in nature, and one of the most potent. The mushrooms have a distinctive conical to bell-shaped cap, up to 2.5 cm (1 in) in diameter, with a small nipple-like protrusion on the top. They are yellow to brown, covered with radial grooves when moist, and fade to a lighter color as they mature. Their stipes tend to be slender and long, and the same color or slightly lighter than the cap. The gill attachment to the stipe is adnexed, and they are initially cream-colored before tinting purple to black as the spores mature. The spores are dark purplish-brown in mass, ellipsoid in shape, and measure 10.5–15 by 6.5–8.5 micrometres.

<i>Psilocybe cyanescens</i> Species of fungus

Psilocybe cyanescens, commonly known as the wavy cap or potent psilocybe, is a species of potent psychedelic mushroom. The main compounds responsible for its psychedelic effects are psilocybin and psilocin. It belongs to the family Hymenogastraceae. A formal description of the species was published by Elsie Wakefield in 1946 in the Transactions of the British Mycological Society, based on a specimen she had recently collected at Kew Gardens. She had begun collecting the species as early as 1910. The mushroom is not generally regarded as being physically dangerous to adults. Since all the psychoactive compounds in P. cyanescens are water-soluble, the fruiting bodies can be rendered non-psychoactive through parboiling, allowing their culinary use. However, since most people find them overly bitter and they are too small to have great nutritive value, this is not frequently done.

<span class="mw-page-title-main">Psilocin</span> Chemical compound

Psilocin is a substituted tryptamine alkaloid and a serotonergic psychedelic substance. It is present in most psychedelic mushrooms together with its phosphorylated counterpart psilocybin. Psilocin is a Schedule I drug under the Convention on Psychotropic Substances. Acting on the 5-HT2A receptors, psilocin modulates the production and reuptake of serotonin. The mind-altering effects of psilocin are highly variable and subjective and resemble those of LSD and DMT.

<span class="mw-page-title-main">Baeocystin</span> Chemical compound

Baeocystin is a zwitterionic alkaloid and analog of psilocybin. It is found as a minor compound in most psilocybin mushrooms together with psilocybin, norbaeocystin, aeruginascin, and psilocin. Baeocystin is an N-demethylated derivative of psilocybin, and a phosphorylated derivative of 4-HO-NMT (4-hydroxy-N-methyltryptamine). The structures at right illustrate baeocystin in its zwitterionic form.

<i>Psilocybe tampanensis</i> Psychedelic mushroom in the family Hymenogastraceae

Psilocybe tampanensis is a very rare psychedelic mushroom in the family Hymenogastraceae. Originally collected in the wild in a sandy meadow near Tampa, Florida, in 1977, the fungus would not be found in Florida again until 44 years later. The original Florida specimen was cloned, and descendants remain in wide circulation. The fruit bodies (mushrooms) produced by the fungus are yellowish-brown in color with convex to conic caps up to 2.4 cm (0.9 in) in diameter atop a thin stem up to 6 cm (2.4 in) long. Psilocybe tampanensis forms psychoactive truffle-like sclerotia that are known and sold under the nickname "philosopher's stones". The fruit bodies and sclerotia are consumed by some for recreational or entheogenic purposes. In nature, sclerotia are produced by the fungus as a rare form of protection from wildfires and other natural disasters.

<span class="mw-page-title-main">Sclerotium</span> Mycelial mass

A sclerotium, is a compact mass of hardened fungal mycelium containing food reserves. One role of sclerotia is to survive environmental extremes. In some higher fungi such as ergot, sclerotia become detached and remain dormant until favorable growth conditions return. Sclerotia initially were mistaken for individual organisms and described as separate species until Louis René Tulasne proved in 1853 that sclerotia are only a stage in the life cycle of some fungi. Further investigation showed that this stage appears in many fungi belonging to many diverse groups. Sclerotia are important in the understanding of the life cycle and reproduction of fungi, as a food source, as medicine, and in agricultural blight management.

<span class="mw-page-title-main">Ethocybin</span> Chemical compound

Ethocybin is a homologue of the mushroom alkaloid psilocybin, and a semi-synthetic psychedelic alkaloid of the tryptamine family. Effects of ethocybin are comparable to those of a shorter LSD or psilocybin trip, although intensity and duration vary depending on dosage, individual physiology, and set and setting.

<i>Pholiotina cyanopus</i> Species of fungus

Pholiotina cyanopus is a species of fungus that contains psychoactive compounds including psilocybin and the uncommon aeruginascin. Originally described as Galerula cyanopus by American mycologist George Francis Atkinson in 1918. It was transferred to Conocybe by Robert Kühner in 1935 before being transferred to Pholiotina by Rolf Singer in 1950. A 2013 molecular phylogenetics study found it to belong to a group of species currently assigned to Pholiotina that are more closely related to Galerella nigeriensis than to Pholiotina or Conocybe. It is likely that it will be moved to a different genus in the future, but this has not happened yet.

Hallucinogens are a large and diverse class of psychoactive drugs that can produce altered states of consciousness characterized by major alterations in thought, mood, and perception as well as other changes. Most hallucinogens can be categorized as either being psychedelics, dissociatives, or deliriants.

The legal status of unauthorised actions with psilocybin mushrooms varies worldwide. Psilocybin and psilocin are listed as Schedule I drugs under the United Nations 1971 Convention on Psychotropic Substances. Schedule I drugs are defined as drugs with a high potential for abuse or drugs that have no recognized medical uses. However, psilocybin mushrooms have had numerous medicinal and religious uses in dozens of cultures throughout history and have a significantly lower potential for abuse than other Schedule I drugs.

Psilocybe subcaerulipes is a species of fungus in the family Hymenogastraceae. It is in the section Zapotecorum of the genus Psilocybe, other members of this section include Psilocybe muliercula, Psilocybe angustipleurocystidiata, Psilocybe aucklandii, Psilocybe collybioides, Psilocybe kumaenorum, Psilocybe zapotecorum, Psilocybe pintonii, Psilocybe graveolens, Psilocybe moseri, Psilocybe zapotecoantillarum, Psilocybe zapotecocaribaea, and Psilocybe antioquiensis. It is endemic to Japan. Fruit bodies grow on the ground in woody debris, and typically stand 6 to 8 cm tall with caps that are 2.5 to 5 cm in diameter. They are chestnut brown, and stain blue if bruised or handled. The species is a psychoactive mushroom, and contains the hallucinogenic compounds psilocybin and psilocin. There have been reports of poisoning caused by the accidental consumption of this mushroom. It has been used in research, specifically, to test the effects of its consumption of marble-burying in mice, an animal model of obsessive-compulsive disorder.

<span class="mw-page-title-main">Harris Isbell</span> American pharmacologist

Harris Isbell was an American pharmacologist and the director of research for the NIMH Addiction Research Center at the Public Health Service Hospital in Lexington, Kentucky from 1945 to 1963. He did extensive research on the physical and psychological effects of various drugs on humans. Early work investigated aspects of physical dependence with opiates and barbiturates, while later work investigated psychedelic drugs, including LSD. The research was extensively reported in academic journals such as the Journal of Pharmacology and Experimental Therapeutics, Psychopharmacologia, and the AMA Archives of Neurology and Psychiatry.

<span class="mw-page-title-main">Steven Hayden Pollock</span> American physician and mycologist (1947–1981)

Steven Hayden Pollock was a mycologist who studied psychoactive mushrooms and published many articles on the potential of mushrooms to treat illness and improve quality of life.

<span class="mw-page-title-main">Psilocybin therapy</span> Experimental use of psilocybin to treat anxiety & depression

Psilocybin therapy is the use of psilocybin in treating a range of mental health conditions, such as depression, anxiety, addictions, obsessive compulsive disorder, and psychosis. It is one of several forms of psychedelic therapy under study. Psilocybin was popularized as a psychedelic recreational drug in the 1970s and was classified as a Schedule I drug by the DEA. Research on psilocybin as a medical treatment was restricted until the 1990s because of the sociocultural fear of dependence on this drug. As of 2022, psilocybin is the most commonly researched psychedelic due to its safety and low potential for abuse and dependence. Clinical trials are being conducted at universities and there is evidence confirming the use of psilocybin in the treatment of depression, PTSD and end of life anxiety.

<span class="mw-page-title-main">MindMed</span> Psychedelic medicine biotech company

Mind Medicine Inc., also known as MindMed, is a New York-based psychedelic medicine biotech company that develops psychedelic-inspired medicines known as psychoplastogens and therapies to address addiction and mental illness.

References

  1. Sterling, Toby (2007-10-13). "Dutch Declare Hallucinogenic Mushrooms Illegal". Washingtonpost.com. Retrieved 2017-11-02.
  2. MacIntyre, James (2007-10-13). "Netherlands imposes total ban on 'magic' mushrooms". London: Independent.co.uk. Retrieved 2017-11-02.
  3. Morris, Hamilton (2012-02-13). "Hamilton and the Philosopher's Stone". Amsterdam: Vice. Retrieved 2017-02-11.
  4. Johnson, Matthew W.; Griffiths, Roland R.; Hendricks, Peter S.; Henningfield, Jack E. (2018). "The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act". Neuropharmacology. 142: 143–166. doi:10.1016/j.neuropharm.2018.05.012. PMC   6791528 . PMID   29753748.
  5. Johansen; Krebs (29 March 2015). "Psychedelics not linked to mental health problems or suicidal behavior: a population study". Journal of Psychopharmacology. 29 (3): 270–279. doi:10.1177/0269881114568039. PMID   25744618. S2CID   2025731.
  6. Aronson (2016). Meyler's Side Effects of Drugs (16 ed.). Elsevier. ISBN   978-0-444-53716-4.
  7. Isbell, Harris; Wolbach, A. B.; Wikler, A.; Miner, E. J. (1961-05-01). "Cross tolerance between LSD and psilocybin". Psychopharmacologia. 2 (3): 147–159. doi:10.1007/BF00407974. ISSN   1432-2072. PMID   13717955. S2CID   7746880.